Express Pharma
NOVEMBER 1, 2024
The world is increasingly looking towards India, not just for our contributions to generic medicines, but for our growing leadership in advanced areas like biologics, medical devices, and digital health.” It’s not just a goal; it is the foundation of our global leadership, and the trust placed in us.
European Pharmaceutical Review
JULY 25, 2023
A compound annual growth rate (CAGR) growth of 5.9 The small molecule API market is influenced by several factors, including heightened R&D within the pharmaceutical sector, a growing prevalence of chronic illnesses and rising demand for generic medicines. This is a rise from $162.8 billion in 2022.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Express Pharma
AUGUST 30, 2023
Krishna Sarma, Managing Partner, Corporate Law Group , said, “The entanglement of Registered Medical Practitioners (RMPs) in third-party activities involving pharmaceutical companies, coupled with the haze surrounding generic medicines, beckons for clarity.
Express Pharma
NOVEMBER 1, 2024
Streamlined regulatory pathways One of the biggest enablers of drug repurposing is the regulatory framework designed to expedite approvals for already-approved compounds. For repurposed drugs, early-stage trials such as Phase 1 or 2 might be sufficient, provided there is existing safety data on the compound,” Vyas explains.
pharmaphorum
OCTOBER 11, 2022
Talking through their generic medicines, of which the company has more than 1,000 projects ongoing, Schultz noted that more than half of the leading medicines on the WHO’s list of medicines are Teva’s. Indeed, of the 281 WHO-listed essential medicines, 100% of respiratory treatments are Teva’s.
Quality Matters
OCTOBER 13, 2021
With this extensive system in place, patients can trust that medicines with the same name will be consistent in quality no matter who manufactures it or where in the world it is made. Since manufacturers know the precise quality specifications, standards help make the approval process for generic medicines more efficient.
pharmaphorum
MAY 26, 2022
Throughout the pandemic, the issue of vaccine hesitancy was compounded by ethnic disparities. Liam Johnstone has six years of toxicology experience working across regulators in the UK, developing expertise in medicine, consumer product and agrochemical safety whilst working at the MHRA, OPSS and HSE, respectively.
Expert insights. Personalized for you.
105 
Let's personalize your content